Abstract:Background: Bacterial resistance to antibiotic therapies is increasing and new treatment options are badly needed. There is an overlap between these resistant bacteria and organisms classified as likely bioterror weapons. For example, Bacillus anthracis is innately resistant to the anti-folate trimethoprim due to sequence changes found in the dihydrofolate reductase enzyme. Development of new inhibitors provides an opportunity to enhance the current arsenal of anti-folate antibiotics while also expanding the coverage of the anti-folate class. Methods: We have characterized inhibitors of B. anthracis dihydrofolate reductase by measuring the K(i) and MIC values and calculating the energetics of binding. This series contains a core diaminopyrimidine ring, a central dimethoxybenzyl ring, and a dihydrophthalazine moiety. We have altered the chemical groups extended from a chiral center on the dihydropyridazine ring of the phthalazine moiety. The interactions for the most potent compounds were visualized by X-ray structure determination. Results: We find that the potency of individual enantiomers is divergent with clear preference for the S-enantiomer, while maintaining a high conservation of contacts within the binding site. The preference for enantiomers seems to be predicated largely by differential interactions with protein residues Leu29, Gln30 and Arg53. Conclusions: These studies have clarified the activity of modifications and of individual enantiomers, and highlighted the role of the less-active R-enantiomer in effectively diluting the more active S-enantiomer in racemic solutions. This directly contributes to the development of new antimicrobials, combating trimethoprim resistance, and treatment options for potential bioterrorism agents.

Determination of the stereochemistry of anhydroerythromycin A, the principal degradation product of the antibiotic erythromycin A

A kinetic study on the degradation of erythromycin A in aqueous solution

Structure elucidation of (+)-amphidinolide a by total synthesis and NMR chemical shift analysis.

Synthesis of hept-6-en-2,4,5-triols and hept-6-en-2,3,5-triols

Controlling Enantioselectivity of Esterase in Asymmetric Hydrolysis of Aryl Prochiral Diesters by Introducing Aromatic Interactions.

The Relative Configurations of Azalomycins F5a, F4a and F3a

The Fate of Erythromycin in Soils and Its Effect on Soil Microbial Community Structure.

Refinement of a low-resolution crystal structure to better understand erythromycin interactions on large ribosomal subunit

Synthesis of the C1–C12 Acid Fragment of Amphidinolide T Marine Macrolides Via SmI2-mediated Enantioselective Reductive Coupling of Aldehydes with a Chiral Crotonate

Synthesis of 3-Hydroxy-6-O-methylerythromycin

Synthesis and Antibacterial Activity of Erythromycin 9-Acylhydrazone Derivates

Structural elucidation of 14-membered ring macrolide antibiotics using electrospray ionization tandem mass spectrometry and density functional theory calculations

Quantitative structure-activity relationships in erythromycin group with MTD technique

Amipurimycin: Total Synthesis of the Proposed Structures and Diastereoisomers

Analyzing atomic scale structural details and nuclear spin dynamics of four macrolide antibiotics: erythromycin, clarithromycin, azithromycin, and roxithromycin

Crystallographic Determination of Stereochemistry of Biologically Active 2 '',3 ''-Dibromo-7-epi-10-deacetylcephalomannine

Structural and functional insights into esterase-mediated macrolide resistance

Scaffold Modifications in Erythromycin Macrolide Antibiotics. A Chemical Minireview

Further Structure-Activity Relationships of the Myxobacterial Antibiotics Cystothiazoles

Structure-activity relationship for enantiomers of potent inhibitors of B. anthracis dihydrofolate reductase

Total Syntheses of (-)-mersicarpine, (-)-scholarisine G, (+)-Melodinine E, (-)-leuconoxine, (-)-leuconolam, (-)-leuconodine A, (+)-Leuconodine F, and (-)-leuconodine C: Self-Induced Diastereomeric Anisochronism (SIDA) Phenomenon for Scholarisine G and Leuconodines A and C.